(19)
(11) EP 2 772 264 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
19.10.2022 Bulletin 2022/42

(45) Mention of the grant of the patent:
03.08.2022 Bulletin 2022/31

(21) Application number: 12843553.4

(22) Date of filing: 24.10.2012
(51) International Patent Classification (IPC): 
A61K 36/48(2006.01)
A61K 129/00(2006.01)
A61P 1/04(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/48; A61P 1/04; A61P 43/00
(86) International application number:
PCT/CN2012/083458
(87) International publication number:
WO 2013/060275 (02.05.2013 Gazette 2013/18)

(54)

APPLICATION OF ALBIZZIA CHINENSIS EXTRACT IN PREPARATION OF MEDICINE FOR TREATMENT OF GASTRIC ULCER

VERWENDUNG EINES ALBIZZIA-CHINENSIS-EXTRAKTS BEI DER HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON MAGENGESCHWÜREN

APPLICATION D'UN EXTRAIT D'ALBIZZIA CHINENSIS DANS LA PRÉPARATION D'UN MÉDICAMENT DESTINÉ AU TRAITEMENT D'UN ULCÈRE GASTRIQUE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 24.10.2011 CN 201110326361

(43) Date of publication of application:
03.09.2014 Bulletin 2014/36

(73) Proprietor: Institute of Materia Medica, Chinese Academy of Medical Sciences
Xuanwu District Beijing 100050 (CN)

(72) Inventors:
  • YU, Shishan
    Beijing 100050 (CN)
  • ZHANG, Jianjun
    Beijing 100050 (CN)
  • MA, Shuanggang
    Beijing 100050 (CN)
  • XU, Ruiming
    Beijing 100050 (CN)
  • JI, Chengxue
    Beijing 100050 (CN)

(74) Representative: De Vries & Metman 
Overschiestraat 180
1062 XK Amsterdam
1062 XK Amsterdam (NL)


(56) References cited: : 
CN-A- 101 766 676
   
  • DATABASE WPI Week 201076 Thomson Scientific, London, GB; AN 2010-K13538 XP002739865, & CN 101 766 676 A (INST MEDICAL MATERIALS CHINESE ACAD MEDI) 7 July 2010 (2010-07-07)
  • DATABASE WPI Week 200903 Thomson Scientific, London, GB; AN 2009-A44154 XP002739866, & CN 101 239 093 A (UNIV JIANGNAN) 13 August 2008 (2008-08-13)
  • G Nagaraja Perumal ET AL: "Anti-inflammatory and ulcer prtotective activities of chloroform extract of Albizzia chinensis bark and its phytochemical studies", 96 Pelagia Research Library INTRODUCTION, 1 January 2010 (2010-01-01), pages 95-103, XP055190326, Retrieved from the Internet: URL:http://pelagiaresearchlibrary.com/der- pharmacia-sinica/vol1-iss1/DPS-2010-1-1-95 -103.pdf [retrieved on 2015-05-20]
  • T. RAJKUMAR ET AL: "Studies on Activity of Various Extracts of Albizia amara against Drug induced Gastric Ulcers", PHARMACOGNOSY JOURNAL, vol. 3, no. 25, 1 September 2011 (2011-09-01), pages 73-77, XP055190325, ISSN: 0975-3575, DOI: 10.5530/pj.2011.25.13
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).